These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 9892518

  • 1. Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel.
    Schrör K.
    Vasc Med; 1998; 3(3):247-51. PubMed ID: 9892518
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity.
    Niitsu Y, Jakubowski JA, Sugidachi A, Asai F.
    Semin Thromb Hemost; 2005 Apr; 31(2):184-94. PubMed ID: 15852222
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Platelet ADP receptor antagonists: ticlopidine and clopidogrel.
    Jacobson AK.
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):55-64. PubMed ID: 15171957
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models.
    Wang YX, Vincelette J, da Cunha V, Martin-McNulty B, Mallari C, Fitch RM, Alexander S, Islam I, Buckman BO, Yuan S, Post JM, Subramanyam B, Vergona R, Sullivan ME, Dole WP, Morser J, Bryant J.
    Thromb Haemost; 2007 May; 97(5):847-55. PubMed ID: 17479197
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A, Virtanen KS, Reséndiz JC, Mikkelsson J, Viiri LE, Karhunen PJ, Lassila R.
    Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
    [Abstract] [Full Text] [Related]

  • 18. Ticlopidine and clopidogrel.
    Quinn MJ, Fitzgerald DJ.
    Circulation; 1999 Oct 12; 100(15):1667-72. PubMed ID: 10517740
    [Abstract] [Full Text] [Related]

  • 19. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
    Hechler B, Eckly A, Ohlmann P, Cazenave JP, Gachet C.
    Br J Haematol; 1998 Dec 12; 103(3):858-66. PubMed ID: 9858246
    [Abstract] [Full Text] [Related]

  • 20. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
    Savi P, Laplace MC, Maffrand JP, Herbert JM.
    J Pharmacol Exp Ther; 1994 May 12; 269(2):772-7. PubMed ID: 8182545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.